Scientist Home Future Health Q2 2026: Cash Drops to $9K, Equity Turns Negative, Going Concern Warning Reiterated
SHFH is trading near its 52-week low of $1.746 (8.8% above the low).
Summary
Scientist Home Future Health's Q2 2026 filing reveals a near-depleted cash position of $9,047, negative equity, and a reiterated going concern warning. The company is surviving on insider support.
Key Events · Earnings and Guidance · SHFH
-
Cash Plummets to $9,047
Cash and cash equivalents fell 87% from $68,888 at year-end 2025 to $9,047 as of June 30, 2026, leaving minimal liquidity.
-
Equity Turns Negative
Stockholders' equity swung from $113,391 to ($86,324) due to a $199,924 net loss for the six months, wiping out all equity.
-
Going Concern Warning Reiterated
Management again expresses substantial doubt about the company's ability to continue as a going concern, citing net current liabilities of $214,975 and ongoing losses.
-
Material Weaknesses Unresolved
The company continues to lack segregation of duties, an independent board, and written internal control policies, with no near-term remediation plan.
Analysis · SHFH · Industrial Applications And Services
The company's financial position has deteriorated sharply. Cash fell from $68,888 at year-end to just $9,047 — barely enough to cover a few weeks of operating expenses. Stockholders' equity swung from positive $113,391 to negative $86,324, meaning liabilities now exceed assets. The going concern warning is reiterated, and management acknowledges substantial doubt about the company's ability to continue. With only $9K in cash and ongoing losses, the company is reliant on insider loans and related-party advances to stay afloat. The unresolved material weaknesses in internal controls add further risk.
At the time of this filing, SHFH was trading at $1.90 on OTC in the Industrial Applications And Services sector. The 52-week trading range was $1.75 to $1.90. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.